Type II collagen

Context

The collagen family has about 28 distinct types with different tissue distributions. Type I collagen is the dominant collagen in skin, bone, and tendons. Type II collagen is the dominant collagen in cartilage and in the vitreous humor of the eye. Each type has different mechanical properties optimized for its tissue role.

In articular cartilage, type II collagen fibers form a three-dimensional network that resists tensile forces, while the hydrated proteoglycan gel between fibers resists compression. Together, they give cartilage its unique combination of elasticity and compressive strength. When type II collagen is cleaved by MMP-13, the scaffold weakens, and the entire matrix begins to lose mechanical integrity.

Why it matters for joint health

Biomarkers of type II collagen breakdown (ex: the C2C neoepitope) are used in research to quantify cartilage turnover. Clinically, preserving type II collagen mass is the structural goal of joint support. Interventions that support matrix synthesis (glucosamine for GAG substrates, collagen peptides for amino acid substrates) and interventions that reduce the signaling driving MMP-13 (NF-kB modulation, 5-LOX modulation) both protect the type II collagen scaffold, from different directions.